Evidence map›Paper›PMID 27497954›Full record

ArticleThe Lancet. Global health2016

State of inequality in diphtheria-tetanus-pertussis immunisation coverage in low-income and middle-income countries: a multicountry study of household health surveys.

Ahmad Reza Hosseinpoor, Nicole Bergen, Anne Schlotheuber, Marta Gacic-Dobo, Peter M Hansen, Kamel Senouci, Ties Boerma, Aluisio J D Barros

Abstract read
In one paragraph

Article in The Lancet. Global health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. The Impact of the COVID-19 Pandemic on Immunization Campaigns and Programs: A Systematic Review.International journal of environmental research and public health · 2021
    Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Ahmad Reza HosseinpoorDepartment of Information, Evidence and Research, World Health Organization, Geneva, Switzerland. Electronic address: hosseinpoora@who.int.
Nicole BergenDepartment of Information, Evidence and Research, World Health Organization, Geneva, Switzerland; Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada.
Anne SchlotheuberDepartment of Information, Evidence and Research, World Health Organization, Geneva, Switzerland.
Marta Gacic-DoboDepartment of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Peter M HansenGavi, the Vaccine Alliance, Geneva, Switzerland.
Kamel SenouciDepartment of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Ties BoermaDepartment of Information, Evidence and Research, World Health Organization, Geneva, Switzerland.
Aluisio J D BarrosInternational Center for Equity in Health, Federal University of Pelotas, Pelotas, Brazil.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundImmunisation programmes have made substantial contributions to lowering the burden of disease in children, but there is a growing need to ensure that programmes are equity-oriented. We aimed to provide a detailed update about the state of between-country inequality and within-country economic-related inequality in the delivery of three doses of the combined diphtheria, tetanus toxoid, and pertussis-containing vaccine (DTP3), with a special focus on inequalities in high-priority countries.

methodsWe used data from the latest available Demographic and Health Surveys and Multiple Indicator Cluster Surveys done in 51 low-income and middle-income countries. Data for DTP3 coverage were disaggregated by wealth quintile, and inequality was calculated as difference and ratio measures based on coverage in richest (quintile 5) and poorest (quintile 1) household wealth quintiles. Excess change was calculated for 21 countries with data available at two timepoints spanning a 10 year period. Further analyses were done for six high-priority countries-ie, those with low national immunisation coverage and/or high absolute numbers of unvaccinated children. Significance was determined using 95% CIs.

findingsNational DTP3 immunisation coverage across the 51 study countries ranged from 32% in Central African Republic to 98% in Jordan. Within countries, the gap in DTP3 immunisation coverage suggested pro-rich inequality, with a difference of 20 percentage points or more between quintiles 1 and 5 for 20 of 51 countries. In Nigeria, Pakistan, Laos, Cameroon, and Central African Republic, the difference between quintiles 1 and 5 exceeded 40 percentage points. In 15 of 21 study countries, an increase over time in national coverage of DTP3 immunisation was realised alongside faster improvements in the poorest quintile than the richest. For example, in Burkina Faso, Cambodia, Gabon, Mali, and Nepal, the absolute increase in coverage was at least 2·0 percentage points per year, with faster improvement in the poorest quintile. Substantial economic-related inequality in DTP3 immunisation coverage was reported in five high-priority study countries (DR Congo, Ethiopia, Indonesia, Nigeria, and Pakistan), but not Uganda.

interpretationOverall, within-country inequalities in DTP3 immunisation persist, but seem to have narrowed over the past 10 years. Monitoring economic-related inequalities in immunisation coverage is warranted to reveal where gaps exist and inform appropriate approaches to reach disadvantaged populations.

fundingNone.

Indexed as

Global HealthSocioeconomic FactorsVaccination CoverageDeveloping CountriesDiphtheria-Tetanus-Pertussis VaccineFemaleHealth SurveysHumansImmunization ProgramsInfantMalePovertyDiphtheria-Tetanus-Pertussis Vaccine

Identifiers

PMID27497954
PMCPMC4985563

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.